SEC Form 4 · accession 0001140361-18-021817
Unity Biotechnology, Inc. · UBX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathaniel E David
Officer — President · Director
Period of report
May 2, 2018
Accepted (ET)
May 4, 2018 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001463361
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $17.00 | May 2, 2018 | A | 47,458 | A | — | May 1, 2028 | Common Stock | 47,458 | 47,458 | D |
Explanation of responses
- F1The shares subject to the option vest as to 25% of the shares on the one-year anniversary of May 2, 2018, and 1/48th of the shares shall vest on each monthly anniversary thereafter, subject to the optionee remainining a service provider to the Issuer on each such vesting date.